A PIPE for PIP (PharmAthene)?
Tweet
Share
E-mailGet Alerts PIP Hot Sheet
Join SI Premium – FREE
There is some chatter going around that after a 200% surge in the stock since last week, PharmAthene, Inc. (AMEX: PIP) could be in the market to raise some cash by selling stock.
Shares of PIP are up 32 percent today, but well off the day's highs as speculation swirls about a PIPE.
The stock has been on fire related to Siga's (Nasdaq: SIGA) smallpox antiviral award with the government, that is worth up to $2.8 billion. PharmAthene is suing Siga for its claim on a partnership for the smallpox antiviral drug. Many are expecting a cash settlement or royalties from SIGA, and some are making the case that shares of PIP could rise to $20 per share.
Shares of PIP are up 32 percent today, but well off the day's highs as speculation swirls about a PIPE.
The stock has been on fire related to Siga's (Nasdaq: SIGA) smallpox antiviral award with the government, that is worth up to $2.8 billion. PharmAthene is suing Siga for its claim on a partnership for the smallpox antiviral drug. Many are expecting a cash settlement or royalties from SIGA, and some are making the case that shares of PIP could rise to $20 per share.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon planning new round of layoffs this week - Barron’s
- Voya Financial Fielded Takeover Interest In Recent Weeks - Semafor
- Susquehanna Starts IBM (IBM) at Neutral
Create E-mail Alert Related Categories
Insiders' Blog, Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
